Tilray missed its earnings forecasts for Q2 and Q3 in 2018. However, there is growth potential that makes the stock attractive even at such a high valuation. Tilray boasts an impressive list of international licenses and is approved to operate in Australia, New Zealand, Canada, Argentina, Germany, Chile, and more. With all their international experience, it’s likely Tilray has intentions to widen its international exposure further. Although the stock has stabilized recently, it frequently exhibits exaggerated reactions when it moves. This cannabis stock isn’t for traders with small appetites for risk. If you can weather the volatility, there’s a chance that building a position in Tilray now will pay off big time in years to come.
Recent Comments